Evidence map›Paper›PMID 30093395›Full record

ArticleHaematologica2018

A double Philadelphia chromosome-positive chronic myeloid leukemia patient, co-expressing P210

Raquel Vinhas, Alexandra Lourenço, Susana Santos, Patrícia Ribeiro, Madalena Silva, Aida Botelho de Sousa, Pedro V Baptista, Alexandra R Fernandes

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Double Philadelphia Chromosomes- A Rare, Yet an Important Cytogenetic Phenomenon of Prognostic Significance in De Novo Acute Lymphoblastic Leukemia.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2022
    Article
  2. Article
  3. Article
  4. Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Raquel VinhasUCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Campus da Caparica.
Alexandra LourençoServiço de Hematologia, Hospital dos Capuchos (CHLC), Lisboa, Portugal.
Susana SantosServiço de Hematologia, Hospital dos Capuchos (CHLC), Lisboa, Portugal.
Patrícia RibeiroServiço de Hematologia, Hospital dos Capuchos (CHLC), Lisboa, Portugal.
Madalena SilvaServiço de Hematologia, Hospital dos Capuchos (CHLC), Lisboa, Portugal.
Aida Botelho de SousaServiço de Hematologia, Hospital dos Capuchos (CHLC), Lisboa, Portugal.
Pedro V BaptistaUCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Campus da Caparica ma.fernandes@fct.unl.pt pmvb@fct.unl.pt.
Alexandra R FernandesUCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Campus da Caparica ma.fernandes@fct.unl.pt pmvb@fct.unl.pt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fusion Proteins, bcr-ablGene Expression Regulation, EnzymologicGene Expression Regulation, LeukemicLeukemia, Myelogenous, Chronic, BCR-ABL PositivePhiladelphia ChromosomeAdultHumansIsoenzymesMaleBCR-ABL1 fusion protein, humanFusion Proteins, bcr-ablIsoenzymes

Identifiers

PMID30093395
PMCPMC6278977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.